Suppressive versus augmenting effect of the same pretreatment regimen in two murine tumor systems with distinct effector mechanisms.
D000818:Animals; D000912:Antibodies, Neoplasm / Q000032:analysis; D000951:Antigens, Neoplasm / Q000276:immunology*; D005260:Female; D006649:Histocompatibility Antigens / Q000276:immunology*; D007111:Immunity, Cellular / Q000528:radiation effects; D007165:Immunosuppression Therapy; D008297:Male; D008325:Mammary Neoplasms, Experimental / Q000276:immunology*; D051379:Mice; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000276:immunology; D010954:Plasmacytoma / Q000276:immunology*; D013601:T-Lymphocytes / Q000276:immunology; D014185:Transplantation, Isogeneic
D000912:Antibodies, Neoplasm; D000951:Antigens, Neoplasm; D006649:Histocompatibility Antigens